289 related articles for article (PubMed ID: 21266670)
1. 17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate.
Yarrow JF; Conover CF; McCoy SC; Lipinska JA; Santillana CA; Hance JM; Cannady DF; VanPelt TD; Sanchez J; Conrad BP; Pingel JE; Wronski TJ; Borst SE
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E650-60. PubMed ID: 21266670
[TBL] [Abstract][Full Text] [Related]
2. 17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement.
McCoy SC; Yarrow JF; Conover CF; Borsa PA; Tillman MD; Conrad BP; Pingel JE; Wronski TJ; Johnson SE; Kristinsson HG; Ye F; Borst SE
Bone; 2012 Oct; 51(4):667-73. PubMed ID: 22842328
[TBL] [Abstract][Full Text] [Related]
3. Influence of aromatase inhibition on the bone-protective effects of testosterone.
Beck DT; Yarrow JF; Beggs LA; Otzel DM; Ye F; Conover CF; Miller JR; Balaez A; Combs SM; Leeper AM; Williams AA; Lachacz SA; Zheng N; Wronski TJ; Borst SE
J Bone Miner Res; 2014 Nov; 29(11):2405-13. PubMed ID: 24764121
[TBL] [Abstract][Full Text] [Related]
4. Influence of androgens on circulating adiponectin in male and female rodents.
Yarrow JF; Beggs LA; Conover CF; McCoy SC; Beck DT; Borst SE
PLoS One; 2012; 7(10):e47315. PubMed ID: 23071783
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle.
Ye F; McCoy SC; Ross HH; Bernardo JA; Beharry AW; Senf SM; Judge AR; Beck DT; Conover CF; Cannady DF; Smith BK; Yarrow JF; Borst SE
Steroids; 2014 Sep; 87():59-66. PubMed ID: 24928725
[TBL] [Abstract][Full Text] [Related]
6. Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle.
Dalbo VJ; Roberts MD; Mobley CB; Ballmann C; Kephart WC; Fox CD; Santucci VA; Conover CF; Beggs LA; Balaez A; Hoerr FJ; Yarrow JF; Borst SE; Beck DT
Andrologia; 2017 Apr; 49(3):. PubMed ID: 27246614
[TBL] [Abstract][Full Text] [Related]
7. The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
Donner DG; Elliott GE; Beck BR; Forwood MR; Du Toit EF
Osteoporos Int; 2016 Mar; 27(3):1073-1082. PubMed ID: 26438310
[TBL] [Abstract][Full Text] [Related]
8. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
Yarrow JF; McCoy SC; Borst SE
Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
[TBL] [Abstract][Full Text] [Related]
9. Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome.
Donner DG; Elliott GE; Beck BR; Bulmer AC; Lam AK; Headrick JP; Du Toit EF
Endocrinology; 2016 Jan; 157(1):368-81. PubMed ID: 26584015
[TBL] [Abstract][Full Text] [Related]
10. Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats.
Donner DG; Beck BR; Bulmer AC; Lam AK; Du Toit EF
Steroids; 2015 Feb; 94():60-9. PubMed ID: 25554582
[TBL] [Abstract][Full Text] [Related]
11. Cross talk between androgen and Wnt signaling potentially contributes to age-related skeletal muscle atrophy in rats.
Mumford PW; Romero MA; Mao X; Mobley CB; Kephart WC; Haun CT; Roberson PA; Young KC; Martin JS; Yarrow JF; Beck DT; Roberts MD
J Appl Physiol (1985); 2018 Aug; 125(2):486-494. PubMed ID: 29722624
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
[TBL] [Abstract][Full Text] [Related]
13. Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase.
Borst SE; Conover CF; Carter CS; Gregory CM; Marzetti E; Leeuwenburgh C; Vandenborne K; Wronski TJ
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E507-14. PubMed ID: 17488806
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
[TBL] [Abstract][Full Text] [Related]
15. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats.
Yarrow JF; Conover CF; Purandare AV; Bhakta AM; Zheng N; Conrad B; Altman MK; Franz SE; Wronski TJ; Borst SE
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767
[TBL] [Abstract][Full Text] [Related]
16. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE
J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747
[TBL] [Abstract][Full Text] [Related]
17. Up to the maximum-testosterone dose-dependent effects on anabolic and androgen responsive tissues in orchiectomized rats.
Derwand D; Zierau O; Thieme D; Keiler AM
Andrology; 2024 Jan; 12(1):231-240. PubMed ID: 37254653
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator.
Piu F; Gardell LR; Son T; Schlienger N; Lund BW; Schiffer HH; Vanover KE; Davis RE; Olsson R; Bradley SR
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):129-37. PubMed ID: 18164613
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
[TBL] [Abstract][Full Text] [Related]
20. Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injury.
Yarrow JF; Conover CF; Beggs LA; Beck DT; Otzel DM; Balaez A; Combs SM; Miller JR; Ye F; Aguirre JI; Neuville KG; Williams AA; Conrad BP; Gregory CM; Wronski TJ; Bose PK; Borst SE
J Neurotrauma; 2014 May; 31(9):834-45. PubMed ID: 24378197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
